These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 7618283)
1. Membrane cofactor protein with different types of N-glycans can serve as measles virus receptor. Maisner A; Herrler G Virology; 1995 Jul; 210(2):479-81. PubMed ID: 7618283 [TBL] [Abstract][Full Text] [Related]
2. Use of site-specific mutagenesis and monoclonal antibodies to map regions of CD46 that interact with measles virus H protein. Hsu EC; Sabatinos S; Hoedemaeker FJ; Rose DR; Richardson CD Virology; 1999 Jun; 258(2):314-26. PubMed ID: 10366568 [TBL] [Abstract][Full Text] [Related]
3. Binding of measles virus to membrane cofactor protein (CD46): importance of disulfide bonds and N-glycans for the receptor function. Maisner A; Schneider-Schaulies J; Liszewski MK; Atkinson JP; Herrler G J Virol; 1994 Oct; 68(10):6299-304. PubMed ID: 8083969 [TBL] [Abstract][Full Text] [Related]
5. The N-glycan of the SCR 2 region is essential for membrane cofactor protein (CD46) to function as a measles virus receptor. Maisner A; Alvarez J; Liszewski MK; Atkinson DJ; Atkinson JP; Herrler G J Virol; 1996 Aug; 70(8):4973-7. PubMed ID: 8764003 [TBL] [Abstract][Full Text] [Related]
6. CD46 as a measles receptor: form follows function. Manchester M; Naniche D; Stehle T Virology; 2000 Aug; 274(1):5-10. PubMed ID: 10936082 [No Abstract] [Full Text] [Related]
7. Blocking measles virus infection with a recombinant soluble form of, or monoclonal antibodies against, membrane cofactor protein of complement (CD46). Seya T; Kurita M; Hara T; Iwata K; Semba T; Hatanaka M; Matsumoto M; Yanagi Y; Ueda S; Nagasawa S Immunology; 1995 Apr; 84(4):619-25. PubMed ID: 7790036 [TBL] [Abstract][Full Text] [Related]
8. Measles virus recognizes its receptor, CD46, via two distinct binding domains within SCR1-2. Manchester M; Gairin JE; Patterson JB; Alvarez J; Liszewski MK; Eto DS; Atkinson JP; Oldstone MB Virology; 1997 Jun; 233(1):174-84. PubMed ID: 9201227 [TBL] [Abstract][Full Text] [Related]
9. High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus. Anderson BD; Nakamura T; Russell SJ; Peng KW Cancer Res; 2004 Jul; 64(14):4919-26. PubMed ID: 15256464 [TBL] [Abstract][Full Text] [Related]
10. A 3D model for the measles virus receptor CD46 based on homology modeling, Monte Carlo simulations, and hemagglutinin binding studies. Mumenthaler C; Schneider U; Buchholz CJ; Koller D; Braun W; Cattaneo R Protein Sci; 1997 Mar; 6(3):588-97. PubMed ID: 9070441 [TBL] [Abstract][Full Text] [Related]
11. Intracellular transport and processing of the Marburg virus surface protein in vertebrate and insect cells. Becker S; Klenk HD; Mühlberger E Virology; 1996 Nov; 225(1):145-55. PubMed ID: 8918541 [TBL] [Abstract][Full Text] [Related]
12. Gangliosides and N-glycoproteins function as Newcastle disease virus receptors. Ferreira L; Villar E; Muñoz-Barroso I Int J Biochem Cell Biol; 2004 Nov; 36(11):2344-56. PubMed ID: 15313478 [TBL] [Abstract][Full Text] [Related]
13. Interactions between the ectodomains of haemagglutinin and CD46 as a primary step in measles virus entry. Devaux P; Loveland B; Christiansen D; Milland J; Gerlier D J Gen Virol; 1996 Jul; 77 ( Pt 7)():1477-81. PubMed ID: 8757989 [TBL] [Abstract][Full Text] [Related]
14. Glycosylation pattern of brush border-associated glycoproteins in enterocyte-like cells: involvement of complex-type N-glycans in apical trafficking. Morelle W; Stechly L; André S; Van Seuningen I; Porchet N; Gabius HJ; Michalski JC; Huet G Biol Chem; 2009 Jul; 390(7):529-44. PubMed ID: 19426135 [TBL] [Abstract][Full Text] [Related]
15. Adaptation of measles virus to polarized epithelial cells: alterations in virus entry and release. Blau DM; Compans RW Virology; 1997 May; 231(2):281-9. PubMed ID: 9168890 [TBL] [Abstract][Full Text] [Related]
16. Multiple amino acid substitutions in hemagglutinin are necessary for wild-type measles virus to acquire the ability to use receptor CD46 efficiently. Tahara M; Takeda M; Seki F; Hashiguchi T; Yanagi Y J Virol; 2007 Mar; 81(6):2564-72. PubMed ID: 17182683 [TBL] [Abstract][Full Text] [Related]
17. Interaction of measles virus (Hallé strain) with CD46: evidence that a common binding site on CD46 facilitates both CD46 downregulation and MV infection. Lecouturier V; Rizzitelli A; Fayolle J; Daviet L; Wild FT; Buckland R Biochem Biophys Res Commun; 1999 Oct; 264(1):268-75. PubMed ID: 10527876 [TBL] [Abstract][Full Text] [Related]
18. Crystal structure of two CD46 domains reveals an extended measles virus-binding surface. Casasnovas JM; Larvie M; Stehle T EMBO J; 1999 Jun; 18(11):2911-22. PubMed ID: 10357804 [TBL] [Abstract][Full Text] [Related]
19. HCV E2 glycoprotein: mutagenesis of N-linked glycosylation sites and its effects on E2 expression and processing. Slater-Handshy T; Droll DA; Fan X; Di Bisceglie AM; Chambers TJ Virology; 2004 Feb; 319(1):36-48. PubMed ID: 14967486 [TBL] [Abstract][Full Text] [Related]
20. Biosynthetic and structural studies on Thy-1 in a rat neuronal tumor cell line. Wilkerson LS; Touster O Arch Biochem Biophys; 1993 Jun; 303(2):238-45. PubMed ID: 8099781 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]